Operose Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Operose Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,000	Closed	-$22.8K	–	658
2024 Q3	$22.8K	Hold	2,000	–	–	0.01%	381
2024 Q2	$14.3K	Hold	2,000	–	–	0.01%	397
2024 Q1	$13.4K	Hold	2,000	–	–	﹤0.01%	445
2023 Q4	$13K	Buy	2,000 +1,225	+158%	+$7.89K	0.01%	425
2023 Q3	$7.32K	Buy	+775	New	+$9.33K	﹤0.01%	620

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Operose Advisors's CDMO Position: Q4 2024 in Review

Operose Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 2,000 shares — an estimated $22.8K sold.

Operose Advisors first reported a position in CDMO in Q3 2023 and held it in 5 quarters. The position peaked at $22.8K in Q3 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

Operose Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Operose Advisors sold 2,000 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $22.8K.
Operose Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2023 and held it in 5 quarters.
Operose Advisors's Avid Bioservices, Inc. Common Stock position peaked at $22.8K in Q3 2024.
195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.